Taysha Gene Therapies (TSHA) EBT Margin (2021 - 2025)
Taysha Gene Therapies' EBT Margin came in at -463.85% for Q4 2025, up 438.92 percentage points from -902.77% a year earlier.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) EBT Margin (2021 - 2025) Analysis & Trends
For FY2025, Taysha Gene Therapies' EBT Margin was -1036.91%, down 21.42 percentage points from FY2024.
- EBT Margin carries a three-year change of +5607.58 percentage points (FY2022 to FY2025).
- Going back by year, EBT Margin was -1015.49% in FY2024 (-537.43 pp), -478.06% in FY2023 (+6166.42 pp) and -6644.48% in FY2022.
- The Q4 2025 figure represents the highest quarterly EBT Margin since Q4 2023.
- Year-over-year, EBT Margin increased in two of the last seven quarters, with an average year-over-year change of -248.43 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Taysha Gene Therapies | 1.52 Bn | 173.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -463.85% |
| Jun 30, 2025 | -1,254.33% |
| Mar 31, 2025 | -873.76% |
| Dec 31, 2024 | -902.77% |
| Sep 30, 2024 | -1,331.94% |
| Jun 30, 2024 | -1,788.31% |
| Mar 31, 2024 | -664.50% |
| Dec 31, 2023 | -417.26% |
| Sep 30, 2023 | -350.02% |
| Jun 30, 2023 | -1,036.49% |
| Mar 31, 2023 | -381.07% |
| Dec 31, 2022 | -27,774.37% |
| Sep 30, 2022 | -294,833.33% |
| Jun 30, 2022 | -126,355.56% |
| Mar 31, 2022 | -359,450.00% |
| Dec 31, 2021 | -173,844.83% |
| Sep 30, 2021 | -138,443.24% |
| Jun 30, 2021 | -102,415.00% |
| Mar 31, 2021 | -48,621.21% |
API Access
Taysha Gene Therapies EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();